FDA Clears ET-600 for Arginine Vasopressin Deficiency on February 25 PDUFA Date
Significant strides in pediatric care emerge as the FDA clears ET-600 for arginine vasopressin deficiency—discover what this means for treatment safety and outcomes.
Read More